浙江昂利康制药股份有限公司关于公司实际控制人股票质押式回购部分购回并解除质押的公告

Core Viewpoint - Zhejiang Anglikang Pharmaceutical Co., Ltd. announced that its actual controller, Mr. Lv Huaihao, has conducted a partial repurchase and release of pledged shares, ensuring that this action will not affect the company's operational governance or control [1][2]. Group 1: Share Pledge and Repurchase Details - As of November 5, 2025, the pledged shares held by the actual controller and their concerted parties have been detailed in the announcement [1]. - The company confirms that the pledged shares do not pose a risk of forced liquidation or transfer, and the actual control of the company remains unchanged [2]. Group 2: Financial Stability and Impact - Mr. Lv Huaihao has a good credit status and possesses the financial capability to repay the pledged shares, indicating no substantial impact on the company's operations or governance [2]. - The company will continue to monitor the changes in share pledges and risks, fulfilling its information disclosure obligations in a timely manner [3].